Myriad Genetics (NASDAQ:MYGN) Releases FY 2023 Earnings Guidance theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Myriad Genetics (NASDAQ:MYGN – Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.08) earnings per share for the quarter, meeting the consensus estimate of ($0.08), Briefing.com reports. The company had revenue of $183.50 million during the quarter, compared to the consensus estimate of $187.16 million. Myriad Genetics had a negative […]
Myriad Genetics (NASDAQ:MYGN – Get Free Report) issued an update on its FY 2023 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of -$0.36–$0.24 for the period, compared to the consensus estimate of -$0.32. The company issued revenue guidance of $730.00 million-$750.00 million, compared to the consensus revenue estimate of […]
The Goldman Sachs Group Increases Myriad Genetics (NASDAQ:MYGN) Price Target to $28.00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Myriad Genetics (NASDAQ:MYGN) Trading 5% Higher on Analyst Upgrade themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.